SIRT1 Silencing Ameliorates Malignancy of Non-Small Cell Lung Cancer via Activating FOXO1

Functional assays in NSCLC cell lines validated the biological capabilities of SIRT1 on malignant phenotypes, and its impact on tumorigenicity was further evaluated in vivo.